Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018799 (
heart disease
)
34,133
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Diabetic mellitus (DM) portends poor prognosis concerning pressure overloaded
heart disease
. Branched-chain amino acids (BCAAs), elements of essential amino acids, have been found altered in its catabolism in diabetes decades ago. However, the relationship between BCAAs and DM induced deterioration of pressure overloaded
heart disease
remains controversial. This study is aimed to investigate the particular effect of
BCKA
, a metabolite of BCAA, on myocardial injury induced by pressure overloaded. Primary cardiomyocytes were incubated with or without
BCKA
and followed by treatment with isoproterenol (ISO); then cell viability was detected by CCK8 and apoptosis was examined by TUNNEL stain and caspase-3 activity analysis. Compared to non-
BCKA
incubated group,
BCKA
incubation decreased cell survival and increased apoptosis concentration dependently. Furthermore, Western blot assay showed that mTORC2-Akt pathway was significantly inactivated by
BCKA
incubation. Moreover, overexpression of rictor, a vital component of mTORC2, significantly abolished the adverse effects of
BCKA
on apoptosis susceptibility of cardiomyocytes. These results indicate that
BCKA
contribute to vulnerability of cardiomyocytes in stimulated stress via inactivation of mTORC2-Akt pathway.
...
PMID:BCKA down-regulates mTORC2-Akt signal and enhances apoptosis susceptibility in cardiomyocytes. 2769 26